DEVICE AND METHOD FOR MANUFACTURING A PREFORM FOR OPTICAL FIBRES BY CHEMICAL VAPOUR DEPOSITION

Details for Australian Patent Application No. 2002321082 (hide)

Owner PIRELLI S.P.A

Inventors Sun, Dongxi; Yang, Michael, X; Sun, Dongxi; Sun, Dongxi; ROBA, Giacomo, Stefano; NUTINI, Massimo; RUZZIER, Marco; VERONELLI, Franco; Chang, Anzhong (Andrew); Yang, Michael, X

Pub. Number AU-A-2002321082

PCT Number PCT/EP02/06778

PCT Pub. Number WO2003/000609

Priority 60/303,410 09.07.01 US; 01202444.4 25.06.01 EP

Filing date 19 June 2002

Wipo publication date 8 January 2003

International Classifications

C03B 037/014 Manufacture or treatment of flakes, fibres, or filaments from softened glass, minerals, or slags - made entirely or partially by chemical means

C03B 037/012 Manufacture or treatment of flakes, fibres, or filaments from softened glass, minerals, or slags - Manufacture of preforms for drawing fibres or filaments

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/303,410 09.07.01 US; 01202444.4 25.06.01 EP

19 June 2003 Application Open to Public Inspection

  Published as AU-A-2002321082

11 March 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002321083-Device for servicing an aircraft on the ground

2002321081-Oral pharmaceutical compositions with improved biovailability